The key role of clinical and community health nurses in pharmacovigilance
- 2 August 2017
- journal article
- review article
- Published by Springer Science and Business Media LLC in European Journal of Clinical Pharmacology
- Vol. 73 (11), 1379-1387
- https://doi.org/10.1007/s00228-017-2309-0
Abstract
The reporting of suspected adverse drug reactions (ADRs) is starting to become routine to nurses. The aim of this review is to underline the role of clinical and community health nurses in pharmacovigilance and to promote their effective participation in ADR reporting in different countries and for patients of different ages.Keywords
This publication has 54 references indexed in Scilit:
- Reporting of adverse drug reactions: an exploratory study among nurses in a teaching hospital, Ajman, United Arab EmiratesDARU Journal of Pharmaceutical Sciences, 2012
- Awareness among nurses about reporting of adverse drug reactions in SwedenDrug, Healthcare and Patient Safety, 2012
- Preventing and Reporting Adverse Drug EventsClinical Nurse Specialist, 2012
- Adverse drug reaction reporting by nurses: analysis of Italian pharmacovigilance databasePharmacoepidemiology and Drug Safety, 2012
- Comparison of knowledge, attitude and practices of resident doctors and nurses on adverse drug reaction monitoring and reporting in a tertiary care hospitalIndian Journal of Pharmacology, 2012
- Health care use and costs of adverse drug events emerging from outpatient treatment in Germany: A modelling approachBMC Health Services Research, 2011
- Adverse Drug Reactions in Hospital In-Patients: A Prospective Analysis of 3695 Patient-EpisodesPLOS ONE, 2009
- Differences in perceived risks and benefits of herbal, over-the-counter conventional, and prescribed conventional, medicines, and the implications of this for the safe and effective use of herbal productsComplementary Therapies in Medicine, 2007
- Under-Reporting of Adverse Drug ReactionsDrug Safety, 2006
- Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patientsBMJ, 2004